Category Archives: Approval Announcements

New Prostate Cancer Treatment Approved by FDA

Ferring Pharmaceuticals is having a good month and have gotten two significant Holiday gifts, as do patients with prostate cancer.  Last week, the CHMP announced approval of Ferring Pharmaceutical's new treatment for prostate cancer, Degelarix.  Today, the FDA followed suit … Continue reading

Posted in Approval Announcements | 1 Comment

Playing Catch-up

I took last week off for the holidays.  Expecting guests, planning menus and my other regular duties left no time for posting and I suspected, little time for others to be reading.  However, in spite of the holidays, things did … Continue reading

Posted in Approval Announcements, Miscellaney | Comments Off

Speaking of Complete Response Letters

Here I am – speaking of Complete Response Letters.  What follows is a short tutorial on the communications aspects of CRLs.     NOTE ADDED OCTOBER 19, 2010 – There has lately been a great deal of interest in this … Continue reading

Posted in Approval Announcements, Complete Response Letters | 5 Comments

More on the Complete Response Letter Track Record and Stock Impact

Last week, I ran a chart on the track record of Complete Response Letters versus approvals from the FDA, demonstrating that the latter is losing in favor of the former.  Since then, the balance of power has changed even further. … Continue reading

Posted in Approval Announcements, Business/Industry News | Comments Off

Full Disclosure on Complete Response Letter by Targanta

Companies take various approaches to revealing the information that is contained in a Complete Response Letter from the FDA, but Targanta Therapeutics Corporation (NASDAQ:  TARG) was very thorough in its press release this week.  It is not uncommon for small … Continue reading

Posted in Approval Announcements | Comments Off